Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Cardiff Lexington Q3 2026 Results: Net Loss of $3.21M, Loss Widens

Cardiff Lexington Corp reported a significant decline in revenue to $6.29 million for the nine months ended September 30, 2026, compared to $8.76 million in the prior year. The company experienced a net loss of $8.78 million for the period, driven by high interest expenses and increased share-based compensation, resulting in a total stockholders' deficit of $283,512.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue1.93.1
Gross profit1.01.9
Net income-3.2-1.1
EPS (diluted, $ a share)$-0.22$-0.21

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year-37.5%
Gross margin54.2%
Operating margin-28.1%
Source

10-Q filed with the SEC, OTC: CDIX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Cardiff Lexington Corp: key numbers

Share price
$0.0050Close, Nov 17
Market cap
$110K
Shares outstanding
22.05MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Offices & Clinics of Doctors of MedicineSIC 8011

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Cardiff Lexington Corp

All →
8:59 AM ET 8-K
M&A Deal

Cardiff Lexington Signs $104M M&A Deal with multi-location musculoskeletal healthcare platform

Cardiff Lexington Corporation has entered into a letter of intent to acquire a multi-location musculoskeletal healthcare platform for up to $104 million. The deal structure includes $30 million in cash, $10 million in notes, and preferred equity representing 35% of the company, plus $12 million in performance-based stock. The acquisition is intended to create a cornerstone regional healthcare platform and expand the company's orthopedic and spine care operations.

Value
$104M
Counterparty
multi-location musculoskeletal healthcare platform

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.